The briefing
AOA Dx released data indicating its multi-omics blood test can detect ovarian, endometrial, and cervical cancers at early stages. The findings suggest a potential screening tool pending further validation and regulatory review.
Original headline
Omics Blood Test from AOA Dx Detects Three Gynecologic Cancers